Advertisement

Topics

Collaboration between Lilly and CRUK progresses to clinical trials

05:45 EDT 23 Aug 2017 | Pharmafile

Cancer Research UK has announced that its collaboration with Eli Lilly for the treatment of advanced solid tumours will progress to the clinic, with trials taking place across four centres in the UK. The studies aim to ascertain the safety and tolerability of the drug involved before moving onto the second phase where efficacy will be judged.

read more

Original Article: Collaboration between Lilly and CRUK progresses to clinical trials

NEXT ARTICLE

More From BioPortfolio on "Collaboration between Lilly and CRUK progresses to clinical trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...